» Articles » PMID: 30831299

Intracranial Angiomatoid Fibrous Histiocytoma with EWSR1-CREB Family Fusions: A Report of 2 Pediatric Cases

Overview
Journal World Neurosurg
Publisher Elsevier
Date 2019 Mar 5
PMID 30831299
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Intracranial angiomatoid fibrous histiocytomas (AFHs) are very rare tumors. Histologically, classical cases have been reported exclusively in adults, with myxoid variants identified only in children. Here, we report the clinical presentation, treatment, biopsy, and molecular test results for 2 children with classical intracranial AFH and combine this with a literature review of published intracranial AFH and AFH-like cases.

Case Description: Two young girls presenting with abnormal neurologic signs, received diagnoses of intracranial AFHs from histopathologic analysis. No myxoid features were identified. Fluorescence in situ hybridization and reverse transcriptase polymerase chain reaction testing demonstrated EWS1-ATF1 and EWS1-CREM gene fusions, respectively, verified by Sanger sequencing. Both patients underwent surgery only. The first child experienced local recurrence 5 years from initial surgery. Following a further complete resection, this patient has remained recurrence free over a subsequent 6-year follow-up period. The second patient has recently experienced local multinodular recurrence 28 months after initial surgery and is awaiting surgical re-excision. No additional chemotherapy/radiotherapy has been administered to either patient.

Conclusions: This report describes the first 2 cases of nonmyxoid intracranial AFH in children; confirmed by molecular analysis. Our results suggest that a tumor spectrum incorporating classical and myxoid intracranial AFHs can occur in children and that gross total resection represents the treatment strategy of choice at diagnosis or following recurrence.

Citing Articles

A Case of Intracranial Mesenchymal Tumor, FET::CREB Fusion-positive, Diagnosed by Genomic Profiling with FoundationOne CDx.

Sono K, Enomoto T, Kobayashi H, Takemoto K, Morishita T, Aoki M NMC Case Rep J. 2025; 12:33-39.

PMID: 40017677 PMC: 11867763. DOI: 10.2176/jns-nmc.2024-0103.


EWSR1::CREM rearranged intra-abdominal malignant epithelioid neoplasm: two new cases of an emerging entity with clinicopathological characteristics and histological pitfalls.

Rusidze M, Poumeaud F, Akiki B, Valentin T, Ferron G, Ducassou A Virchows Arch. 2025; .

PMID: 39888444 DOI: 10.1007/s00428-025-04034-4.


Central nervous system tumors of uncertain differentiation.

Jacobo J World Neurosurg X. 2024; 22:100349.

PMID: 38455248 PMC: 10918257. DOI: 10.1016/j.wnsx.2024.100349.


Potential prognostic determinants for FET::CREB fusion-positive intracranial mesenchymal tumor.

Mezzacappa F, Smith F, Zhang W, Gard A, Kusku Cabuk F, Gonzalez-Gomez I Acta Neuropathol Commun. 2024; 12(1):17.

PMID: 38291529 PMC: 10826246. DOI: 10.1186/s40478-024-01721-2.


Case Report: Remarkable breakthrough: successful treatment of a rare intracranial mesenchymal, FET::CREB fusion-positive tumor treated with patient-tailored multimodal therapy.

DAntonio F, Rossi S, Giovannoni I, Alaggio R, Carai A, Milano G Front Oncol. 2023; 13:1203994.

PMID: 38094610 PMC: 10716272. DOI: 10.3389/fonc.2023.1203994.